HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP3 receptor / Bcl-2 complexes

International Journal of Developmental Biology

Volumn 59, Issue 7-9, 2015, Pages 391-398

  Akl, Haidar ^a   La Rovere, Rita M L ^a,b   Janssens, Ann ^c   Vandenberghe, Peter ^d   Parys, Jan B ^a   Bultynck, Geert ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Bcl 2; Ca2+; Cancer; IP3R

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; BCL2 PROTEIN, HUMAN; BENZOPYRAN DERIVATIVE; ETHYL 2-AMINO-6-BROMO-4-(1-CYANO-2-ETHOXY-2-OXOETHYL)-4H-CHROMENE-3-CARBOXYLATE; NITRILE;

ADULT; APOPTOSIS; ARTICLE; BINDING AFFINITY; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROPHOBICITY; LARGE CELL LYMPHOMA; MITOCHONDRION; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SEQUENCE HOMOLOGY; B LYMPHOCYTE; DIFFUSE LARGE B CELL LYMPHOMA; DRUG EFFECTS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; B-LYMPHOCYTES; BENZOPYRANS; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LYMPHOMA, LARGE B-CELL, DIFFUSE; NITRILES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84947907997     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.150213gb     Document Type: Article

References (34)

1. 3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis 4: e632.
2. AKL, H., VANDECAETSBEEK, I., MONACO, G., KAUSKOT, A., LUYTEN, T., WELKENHUYZEN, K., HOYLAERTS, M., DE SMEDT, H., PARYS, J. B. and BULTYNCK, G. (2013b). HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines. Haematologica 98: e49-51.
3. AKL, H., VERVLOESSEM, T., KIVILUOTO, S., BITTREMIEUX, M., PARYS, J. B., DE SMEDT, H. and BULTYNCK, G. (2014). A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. Biochim Biophys Acta 1843: 2240-2252.
4. CERTO, M., DEL GAIZO MOORE, V., NISHINO, M., WEI, G., KORSMEYER, S., ARMSTRONG, S. A. and LETAI, A. (2006). Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9: 351-365.
5. CHEN, R., VALENCIA, I., ZHONG, F., MCCOLL, K. S., RODERICK, H. L., BOOTMAN, M. D., BERRIDGE, M. J., CONWAY, S. J., HOLMES, A. B., MIGNERY, G. A. et al., (2004). Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol 166: 193-203.
6. CHIPUK, J. E. and GREEN, D. R. (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164.
7. CHIPUK, J. E., MOLDOVEANU, T., LLAMBI, F., PARSONS, M. J. and GREEN, D. R. (2010). The BCL-2 family reunion. Mol Cell 37: 299-310.
8. CHONGHAILE, T. N. and LETAI, A. (2008). Mimicking the BH3 domain to kill cancer cells. Oncogene 27 Suppl 1: S149-157.
9. DECUYPERE, J. P., WELKENHUYZEN, K., LUYTEN, T., PONSAERTS, R., DEWAELE, M., MOLGO, J., AGOSTINIS, P., MISSIAEN, L., DE SMEDT, H., PARYS, J. B. et al., (2011). Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. Autophagy 7: 1472-1489.
10. DEL GAIZO MOORE, V., BROWN, J. R., CERTO, M., LOVE, T. M., NOVINA, C. D. and LETAI, A. (2007). Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest 117: 112-121.
11. DEL GAIZO MOORE, V., SCHLIS, K. D., SALLAN, S. E., ARMSTRONG, S. A. and LETAI, A. (2008). BCL-2 dependence and ABT-737 sensitivity in acute lympho-blastic leukemia. Blood 111: 2300-2309.
12. DENG, J., CARLSON, N., TAKEYAMA, K., DAL CIN, P., SHIPP, M. and LETAI, A. (2007). BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12: 171-185.
13. DISTELHORST, C. W. and BOOTMAN, M. D. (2011). Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca2+ signaling and disease. Cell Calcium 50: 234-241.
14. GIORGI, C., BONORA, M., MISSIROLI, S., POLETTI, F., RAMIREZ, F. G., MORCIANO, M., PANDOLFI, P. P., MAMMANO, F. and PINTON, P. (2015). Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget. 6:1435-1445.
15. HARPER, M. T. and POOLE, A. W. (2012). Bcl-xL-inhibitory BH3 mimetic ABT-737 depletes platelet calcium stores. Blood 119: 4337-4338.
16. HERMANSON, D., ADDO, S. N., BAJER, A. A., MARCHANT, J. S., DAS, S. G., SRINIVASAN, B., AL-MOUSA, F., MICHELANGELI, F., THOMAS, D. D., LEBIEN, T. W. et al., (2009). Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria. Mol Pharmacol 76: 667-678.
17. IVANOVA, H., VERVLIET, T., MISSIAEN, L., PARYS, J. B., DE SMEDT, H. and BUL-TYNCK, G. (2014). Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta 1843: 2164-2183.
18. KODAMA, T., TAKEHARA, T., HIKITA, H., SHIMIZU, S., SHIGEKAWA, M., LI, W., MIYAGI, T., HOSUI, A., TATSUMI, T., ISHIDA, H. et al., (2011). BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. J Biol Chem 286: 13905-13913.
19. LETAI, A. G. (2008). Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 8: 121-132.
20. MASON, K. D., CARPINELLI, M. R., FLETCHER, J. I., COLLINGE, J. E., HILTON, A. A., ELLIS, S., KELLY, P. N., EKERT, P. G., METCALF, D., ROBERTS, A. W. et al., (2007). Programmed anuclear cell death delimits platelet life span. Cell 128: 1173-1186.
21. MISSIAEN, L., VANOEVELEN, J., PARYS, J. B., RAEYMAEKERS, L., DE SMEDT, H., CALLEWAERT, G., ERNEUX, C. and WUYTACK, F. (2002). Ca2+ uptake and release properties of a thapsigargin-insensitive nonmitochondrial Ca2+ store in A7r5 and 16HBE14o- cells. J Biol Chem 277: 6898-6902.
22. MONACO, G., DECROCK, E., AKL, H., PONSAERTS, R., VERVLIET, T., LUYTEN, T., DE MAEYER, M., MISSIAEN, L., DISTELHORST, C. W., DE SMEDT, H. et al., (2012). Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Cell Death Differ 19: 295-309.
23. RONG, Y. P., AROMOLARAN, A. S., BULTYNCK, G., ZHONG, F., LI, X., MCCOLL, K., MATSUYAMA, S., HERLITZE, S., RODERICK, H. L., BOOTMAN, M. D. et al., (2008). Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell 31: 255-265.
24. RONG, Y. P., BULTYNCK, G., AROMOLARAN, A. S., ZHONG, F., PARYS, J. B., DE SMEDT, H., MIGNERY, G. A., RODERICK, H. L., BOOTMAN, M. D. and DISTEL-HORST, C. W. (2009). The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci USA 106: 14397-14402.
25. SAROSIEK, K. A., CHI, X., BACHMAN, J. A., SIMS, J. J., MONTERO, J., PATEL, L., FLANAGAN, A., ANDREWS, D. W., SORGER, P. and LETAI, A. (2013). BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response. Mol Cell 51: 751-765.
26. SCHOENWAELDER, S. M. and JACKSON, S. P. (2012). Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function. Blood 119: 1320-1321.
27. SOUERS, A. J., LEVERSON, J. D., BOGHAERT, E. R., ACKLER, S. L., CATRON, N. D., CHEN, J., DAYTON, B. D., DING, H., ENSCHEDE, S. H., FAIRBROTHER, W. J. et al., (2013). ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19: 202-208.
28. TAIT, S. W. and GREEN, D. R. (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632.
29. VERVLIET, T., DECROCK, E., MOLGO, J., SORRENTINO, V., MISSIAEN, L., LEYBAERT, L., DE SMEDT, H., KASRI, N. N., PARYS, J. B. and BULTYNCK, G. (2014). Bcl-2 binds to and inhibits ryanodine receptors. J Cell Sci 127: 2782-2792.
30. VERVLOESSEM T., YULE, D. I., BULTYNCK, G. and PARYS, J. B. (2015). The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel. Biochim. Biophys. Acta 1853: 1992-2005.
31. VOGLER, M., HAMALI, H. A., SUN, X. M., BAMPTON, E. T., DINSDALE, D., SNOWDEN, R. T., DYER, M. J., GOODALL, A. H. and COHEN, G. M. (2011). BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 117: 7145-7154.
32. VOGLER, M., WEBER, K., DINSDALE, D., SCHMITZ, I., SCHULZEOSTHOFF, K., DYER, M. J. and COHEN, G. M. (2009). Different forms of cell death induced by putative BCL2 inhibitors. Cell Death Differ 16: 1030-1039.
33. WANG, J. L., LIU, D., ZHANG, Z. J., SHAN, S., HAN, X., SRINIVASULA, S. M., CROCE, C. M., ALNEMRI, E. S. and HUANG, Z. (2000). Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA 97: 7124-7129.
34. ZHONG, F., HARR, M. W., BULTYNCK, G., MONACO, G., PARYS, J. B., DE SMEDT, H., RONG, Y. P., MOLITORIS, J. K., LAM, M., RYDER, C. et al., (2011). Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood 117: 2924-2934.